DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 4,645.00
-355.00 (-7.10%)
At close: Apr 2, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 114.16 billion as of April 2, 2026. Its market cap has increased by 65.98% in one year.
Market Cap
114.16B
Enterprise Value
103.46B
Revenue
66.63B
Ranking
n/a
PE Ratio
15.59
Stock Price
4,645.00
Market Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 114.16B, a decrease of -30.93%. That is a compound annual growth rate of -6.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 114.16B | -24.81% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 569.54B |
| HLB bioStep | 106.35B |
| P&K Skin Research Center | 59.35B |
| C&R Research | 46.49B |
| WOOJUNG BIO | 44.43B |
| DT&CRO CO. | 42.70B |
| SLS BIO | 26.89B |
| BioInfra | 19.70B |